Mesa Laboratories, Inc.: stock overview

MLABNASDAQIndustrials · Industrial Instruments For Measurement, Display, and Control

Price

$139.01

November 13, 2026Market cap $768M

What Ploutos Investor adds for Mesa Laboratories

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from FY2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

In short

Mesa Laboratories had revenue of $251M over the last 12 months and net income of $6.7M, a net margin of 2.7%. Revenue grew by 13.2% a year on average over the last 5 years. At $139.01 the shares trade at a P/E of 115.2. It pays a dividend yielding 0.46%.

From its SEC filings (latest fiscal year to March 31, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$768M
5.52M shares
P/E
115.2
Revenue, 12 months
$251M
+13.2% a year over 5 years
Net margin
2.7%
above 56% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+7.3% a year over 2 years

  • FY2026Mar 31, 202610-K
    Revenue$249M
  • FY2025Mar 31, 202510-K
    Revenue$241M
  • FY2024Mar 31, 202410-K
    Revenue$216M

Fiscal years in figures

MLAB's revenue, profit, cash flow and dividend with each year-end price, from FY2011 to FY2023, 13 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $594M
$768M
Enterprise value 
–
P/E 
115.2
EV / EBIT 
–
EV / Revenue 
–
P/B 3-year median: 4.1
4.0
FCF yield 3-year median: 7.0%
6.4%
Earnings yield 3-year median: -0.3%
0.9%

Profitability

Gross margin 
64.8%
Operating margin 
10.4%
Net margin 3-year median: -0.8%
2.7%
ROIC 
7.0%
ROIC, 5-year average 
-11.4%
ROE 
3.6%

Growth

Revenue, yearly change 
+3.4%
EPS, yearly change 
–
FCF, yearly change 
-7.0%
Revenue, average a year 
+13.2%
EPS, average a year 
+13.6%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$22M
Total debt 
–
Net cash 
–
Net debt / EBITDA 
–
Interest cover 
2.6x
Current ratio 
1.90

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 3-year median: 0.6%
0.46%
Buybacks 
–
Total returned 
0.46%
Shares, yearly change 
+1.3%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

63.5%

Above 65% of the 161 companies in its industry, and 81% of all.

Operating margin

7.4%

Above 58% of the 186 companies in its industry, and 57% of all.

Net margin

2.7%

Above 56% of the 189 companies in its industry, and 44% of all.

ROE

3.6%

Above 55% of the 174 companies in its industry, and 39% of all.

ROA

1.5%

Above 56% of the 190 companies in its industry, and 51% of all.

Revenue growth

3.4%

Above 34% of the 186 companies in its industry, and 40% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
MESA LABORATORIES INC /CO/
Exchange
NASDAQ
Industry (SIC)
3823 · Industrial Instruments For Measurement, Display, and Control
Fiscal year ends
March 31
Latest annual report
March 31, 2026
Reporting currency
USD
Shares
5.52M

Other companies: Industrials

The largest companies of the same sector, each with its own page.

The Industrials sectorAll companies

The full analysis

What do Mesa Laboratories's filings show?

These are Mesa Laboratories's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about MLAB

Didn't find what you were looking for?

Ask us
What is MLAB's market cap?

Mesa Laboratories, Inc.'s market cap is $768M, at a price of $139.01 on November 13, 2026 and 5.52M shares.

What is MLAB's P/E?

MLAB's P/E is 115.2, on earnings per share of $1.15 over the last 12 months.

How much revenue does MLAB have?

Mesa Laboratories had revenue of $251M over the last 12 months. Over the last 5 years it changed by +13.2% a year on average.

Does MLAB pay a dividend?

Yes. Mesa Laboratories paid $0.64 per share over the last 12 months, a yield of 0.46% at today's price. All the figures are in the Dividend section.

Where do the figures come from?

From Mesa Laboratories, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.